Although ovarian cancer comprises only 3% of all women’s cancers, it is the fifth leading cause of women’s cancer deaths. Women who are diagnosed with advanced stage ovarian cancer have a long-term survival rate of only 10%.
When detected in its earliest stages, ovarian cancer survival rates can be as high as 90%. However, early stage symptoms are usually difficult to diagnose, are often misdiagnosed, or go undetected, which leads to nearly 75% of all ovarian cancer patients being diagnosed in advanced stages.
Through innovative research and scientific community collaboration, we can work together to reduce and prevent this disease that disproportionately affects women. We are working to support ovarian cancer research in honor of our wives, mothers, sisters, daughters, and friends.
The Marsha Rivkin Center for Ovarian Cancer Research has been working to save lives and reduce suffering through the prevention of ovarian cancer, early detection, and improved treatment. Through community donations, the Marsha Rivkin Center works to advance research related to ovarian cancer nationwide, and improve outcomes for women facing ovarian cancer. The annual SummeRun, presented by Swedish, is a particularly unique community event and fundraising opportunity that supports ovarian cancer research and the Marsha Rivkin Center’s mission.
SummeRun 2013 Race Details